NASDAQ:AVTX

Avalo Therapeutics Stock Forecast

etoro logo Buy AVTX
*Your capital is at risk
$19.21
-0.740 (-3.71%)
At Close: Jul 10, 2026
AI Analysis AI Analysis of AVTX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add AVTX to Watchlist?
Some Reasons Why To Add AVTX:
  • +301.9% price growth over the last year
  • Bullish trend confirmed on both short and long timeframes
  • Highly efficient cash conversion (100% FCF/OCF ratio)
PDF

High volatility in Avalo Therapeutics, Inc. stock price on Friday which ended trading at $19.21
(Updated on Jul 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy candidate since Jun 22, 2026 Gain 12.47%

The Avalo Therapeutics, Inc. stock price fell by -3.71% on the last day (Friday, 10th Jul 2026) from $19.95 to $19.21. During the last trading day the stock fluctuated 11.02% from a day low at $18.42 to a day high of $20.45. The price has been going up and down for this period, and there has been a 6.72% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -150 thousand shares and in total, 853 thousand shares were bought and sold for approximately $16.38 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 14.30% during the next 3 months and, with a 90% probability hold a price between $15.85 and $28.67 at the end of this 3-month period.

AVTX Signals & Forecast

The Avalo Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $19.10 and $16.29. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, July 06, 2026, and so far it has fallen -3.76%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Avalo Therapeutics, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $18.20 and $17.08. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Avalo Therapeutics, Inc. finds support just below today's level at $18.20. If this is broken, then the next support from accumulated volume will be at $17.08 and $14.70.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $2.03 between high and low, or 11.02%. For the last week, the stock has had daily average volatility of 7.29%.

Our recommended stop-loss: $18.28 (-4.82%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 4 days ago.)

Trading Expectations (AVTX) For The Upcoming Trading Day Of Monday 13th

For the upcoming trading day on Monday, 13th we expect Avalo Therapeutics, Inc. to open at $19.36, and during the day (based on 14 day Average True Range), to move between $18.53 and $19.89, which gives a possible trading interval of +/-$1.36 (+/-7.35%) up or down from last closing price. If Avalo Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 7.35% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $18.20 (5.26%) than the resistance at $20.25 (5.41%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Avalo Therapeutics, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Avalo Therapeutics, Inc. stock to perform well in the short-term.

Current score: 3.521 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 13, 2026 - $19.36 ( 0.781%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

AVTX Performance

Trading levels for AVTX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 21.39 11.35%
R2 20.61 7.31%
R1 20.14 4.82%
Price 19.21
S1 18.58 -3.26%
S2 18.11 -5.75%
S3 17.33 -9.79%

Accumulated Volume Support & Resistance Levels

Level Price
R3 22.87 19.05%
R2 21.81 13.53%
R1 20.25 5.41%
Price 19.21
S1 18.20 -5.26%
S2 17.08 -11.09%
S3 14.70 -23.48%

FAQ

What is the symbol for Avalo Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Avalo Therapeutics, Inc. is AVTX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Avalo Therapeutics, Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Avalo Therapeutics, Inc. stock to perform well in the short-term.

How to buy Avalo Therapeutics, Inc. Stock?
Avalo Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Avalo Therapeutics, Inc. Stock.

What's the current price of Avalo Therapeutics, Inc. Stock?
As of the end of day on the Jul 10, 2026, the price of an Avalo Therapeutics, Inc. (AVTX) share was $19.21.

What is the 52-week high and low for Avalo Therapeutics, Inc. Stock?
The 52-week high for Avalo Therapeutics, Inc. Stock is $24.25 and the 52-week low is $4.72.

What is the market capitalization of Avalo Therapeutics, Inc. Stock?
As of the Jul 10, 2026, the market capitalization of Avalo Therapeutics, Inc. is 216.96M.

When is the next earnings date for Avalo Therapeutics, Inc.?
The upcoming earnings date for Avalo Therapeutics, Inc. is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT AVALO THERAPEUTICS, INC.
Avalo Therapeutics
Avalo Therapeutics, Inc., a clinical-stage precision medicine company, discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. It develops AVTX-002, a fully human anti-LIGHT monoclonal antibody, which is under Phase II clinical trial for the treatment of non-eosinophilic asthma, as well as inflammatory bowel disease, including moderate to severe...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
11.34% Jun 29
NMRK
$15.02
1.20% Jun 24
NESR
$25.07
14.16% Jun 23
CAG
$13.43
2.98% Jun 23
GIB
$66.69
0.555% Jun 12

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE